Cited by 735Cannabis and Cannabinoid ResearchParkinson's Disease Mechanisms and TreatmentsNeuroscience and Neuropharmacology Research

The DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.

Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models

Kreitzer, Anatol C., Malenka, Robert C.·2007·Nature

DOI 10.1038/nature05506

Open this paper in CoChat — free account

Abstract

The striatum is a major forebrain nucleus that integrates cortical and thalamic afferents and forms the input nucleus of the basal ganglia. Striatal projection neurons target the substantia nigra pars reticulata (direct pathway) or the lateral globus pallidus (indirect pathway). Imbalances between neural activity in these two pathways have been proposed to underlie the profound motor deficits observed in Parkinson's disease and Huntington's disease. However, little is known about differences in cellular and synaptic properties in these circuits. Indeed, current hypotheses suggest that these cells express similar forms of synaptic plasticity. Here we show that excitatory synapses onto indirect-pathway medium spiny neurons (MSNs) exhibit higher release probability and larger N-methyl-d-aspartate receptor currents than direct-pathway synapses. Moreover, indirect-pathway MSNs selectively express endocannabinoid-mediated long-term depression (eCB-LTD), which requires dopamine D2 receptor activation. In models of Parkinson's disease, indirect-pathway eCB-LTD is absent but is rescued by a D2 receptor agonist or inhibitors of endocannabinoid degradation. Administration of these drugs together in vivo reduces parkinsonian motor deficits, suggesting that endocannabinoid-mediated depression of indirect-pathway synapses has a critical role in the control of movement. These findings have implications for understanding the normal functions of the basal ganglia, and also suggest approaches for the development of therapeutic drugs for the treatment of striatal-based brain disorders.

Integrity signals

Registry

Crossref · 10.1038/nature05506

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The functional anatomy of basal ganglia disorders
Albin, R. L., Young, A. B., & Penney, J. B. (1989) · Trends in Neurosciences · doi:10.1016/0166-2236(89)90074-x · Cited by 5,353
Short-Term Synaptic Plasticity
Zucker, R. S., & Regehr, W. G. (2002) · Annual Review of Physiology · doi:10.1146/annurev.physiol.64.092501.114547 · Cited by 5,068
Glutamate receptor ion channels
Mayer, M. L. (2005) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2005.05.004 · Cited by 3,655
The Synaptic Organization of the Brain
(2004) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195159561.001.1 · Cited by 3,574
The Glutamate Receptor Ion Channels
Dingledine, R., Borges, K., Bowie, D., & Traynelis, S. F. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01394-2 · Cited by 3,554
D 1 and D 2 Dopamine Receptor-regulated Gene Expression of Striatonigral and Striatopallidal Neurons
Gerfen, C. R., Engber, T. M., Mahan, L. C., Susel, Z., Chase, T. N., Monsma, F. J., & Sibley, D. R. (1990) · Science · doi:10.1126/science.2147780 · Cited by 2,967
A gene expression atlas of the central nervous system based on bacterial artificial chromosomes
Gong, S., Zheng, C., Doughty, M. L., Losos, K., Didkovsky, N., Schambra, U. B., Nowak, N. J., Joyner, A., Leblanc, G., Hatten, M. E., et al. (2003) · Nature · doi:10.1038/nature02033 · Cited by 2,108
Modulation of anxiety through blockade of anandamide hydrolysis
Kathuria, S., Gaetani, S., Fegley, D., Valiño, F., Duranti, A., Tontini, A., Mor, M., Tarzia, G., Rana, G. L., Calignano, A., et al. (2003) · Nature Medicine · doi:10.1038/nm803 · Cited by 1,293
Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice
Zimmer, A., Zimmer, A. M., Hohmann, A. G., Herkenham, M. A., & Bonner, T. I. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5780 · Cited by 1,078
The basal ganglia
Graybiel, A. M. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00593-5 · Cited by 1,051

Show all 35 references

Sorted by citations

Items 101–200 of 732

Awareness and current knowledge of Parkinson’s disease: a neurodegenerative disorder
Khan, A. U., Akram, M., Daniyal, M., & Zainab, R. (2018) · International Journal of Neuroscience · doi:10.1080/00207454.2018.1486837 · Cited by 151
Dopaminergic Modulation of Endocannabinoid-Mediated Plasticity at GABAergic Synapses in the Prefrontal Cortex
Chiu, C. Q., Puente, N., Grandes, P., & Castillo, P. E. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.0736-10.2010 · Cited by 143
Dopaminergic modulation of striatal neurons, circuits, and assemblies
Surmeier, D. J., Carrillo‐Reid, L., & Bargas, J. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.08.051 · Cited by 141
Single dose of a dopamine agonist impairs reinforcement learning in humans: Evidence from event‐related potentials and computational modeling of striatal‐cortical function
Santesso, D. L., Evins, A. E., Frank, M. J., Schetter, E. C., Bogdan, R., & Pizzagalli, D. A. (2008) · Human Brain Mapping · doi:10.1002/hbm.20642 · Cited by 143
Integrating synaptic plasticity and striatal circuit function in addiction
Grueter, B. A., Rothwell, P. E., & Malenka, R. C. (2011) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2011.09.009 · Cited by 146
Self-citation
Endocannabinoids in Synaptic Plasticity and Neuroprotection
Xu, J., & Chen, C. (2014) · The Neuroscientist · doi:10.1177/1073858414524632 · Cited by 143
Differential Electrophysiological Changes in Striatal Output Neurons in Huntington's Disease
André, V. M., Cepeda, C., Fisher, Y. E., Huynh, M. N., Bardakjian, N., Singh, S., Yang, X. W., & Levine, M. S. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.3539-10.2011 · Cited by 138
Membrane Properties of Striatal Direct and Indirect Pathway Neurons in Mouse and Rat Slices and Their Modulation by Dopamine
Planert, H., Berger, T. K., & Silberberg, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057054 · Cited by 137
Adenosine Receptor Control of Cognition in Normal and Disease
Chen, J. (2014) · International review of neurobiology · doi:10.1016/b978-0-12-801022-8.00012-x · Cited by 142
Inhibition of phosphodiesterases rescues striatal long-term depression and reduces levodopa-induced dyskinesia
Picconi, B., Bagetta, V., Ghiglieri, V., Paillé, V., Filippo, M. D., Pendolino, V., Tozzi, A., Giampà, C., Fusco, F. R., Sgobio, C., et al. (2010) · Brain · doi:10.1093/brain/awq342 · Cited by 140
Dopaminergic signaling in dendritic spines
Yao, W., Spealman, R. D., & Zhang, J. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.01.018 · Cited by 142
A53T-Alpha-Synuclein Overexpression Impairs Dopamine Signaling and Striatal Synaptic Plasticity in Old Mice
Kurz, A., Double, K. L., Lastres‐Becker, I., Tozzi, A., Tantucci, M., Bockhart, V., von Bonin, M., García-Arencibia, M., Nuber, S., Schlaudraff, F., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011464 · Cited by 137
Pathway- and Cell-Specific Kappa-Opioid Receptor Modulation of Excitation-Inhibition Balance Differentially Gates D1 and D2 Accumbens Neuron Activity
Tejeda, H. A., Wu, J., Kornspun, A. R., Pignatelli, M., Kashtelyan, V., Krashes, M. J., Lowell, B. B., Carlezon, W. A., & Bonci, A. (2017) · Neuron · doi:10.1016/j.neuron.2016.12.005 · Cited by 141
Bidirectional and long-lasting control of alcohol-seeking behavior by corticostriatal LTP and LTD
Ma, T., Cheng, Y., Roltsch, E. A., Wang, X., Lu, J., Gao, X., Huang, C. C., Wei, X.-Y., Ji, J., & Wang, J. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0081-9 · Cited by 141
Oxidation of the Endogenous Cannabinoid Arachidonoyl Ethanolamide by the Cytochrome P450 Monooxygenases: Physiological and Pharmacological Implications
Snider, N. T., Walker, V. J., & Hollenberg, P. F. (2010) · Pharmacological Reviews · doi:10.1124/pr.109.001081 · Cited by 136
Opposing Roles of Synaptic and Extrasynaptic NMDA Receptor Signaling in Cocultured Striatal and Cortical Neurons
Kaufman, A. M., Milnerwood, A. J., Sepers, M. D., Coquinco, A., She, K., Wang, L., Lee, H., Craig, A. M., Cynader, M. S., & Raymond, L. A. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.4129-11.2012 · Cited by 135
Role of basal ganglia neurocircuitry in the pathology of psychiatric disorders
Macpherson, T., & Hikida, T. (2019) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12830 · Cited by 138
Enhanced GABA Transmission Drives Bradykinesia Following Loss of Dopamine D2 Receptor Signaling
Lemos, J. C., Friend, D. M., Kaplan, A. R., Shin, J. H., Rubinstein, M., Kravitz, A. V., & Alvarez, V. A. (2016) · Neuron · doi:10.1016/j.neuron.2016.04.040 · Cited by 130
Adenosine–cannabinoid receptor interactions. Implications for striatal function
Ferré, S., Lluı́s, C., Justinová, Z., Quiroz, C., Orrù, M., Navarro, G., Canela, E. I., Franco, R., & Goldberg, S. R. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00723.x · Cited by 129
Synaptic plasticity in the mesolimbic system
Chen, B. T., Hopf, F. W., & Bonci, A. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05154.x · Cited by 130
Inhibition of Phosphodiesterase 10A Increases the Responsiveness of Striatal Projection Neurons to Cortical Stimulation
Threlfell, S., Sammut, S., Menniti, F. S., Schmidt, C. J., & West, A. R. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.146332 · Cited by 128
Corticostriatal synaptic function in mouse models of Huntington's disease: early effects of huntingtin repeat length and protein load
Milnerwood, A. J., & Raymond, L. A. (2007) · The Journal of Physiology · doi:10.1113/jphysiol.2007.142448 · Cited by 126
Convergence of cortical and thalamic input to direct and indirect pathway medium spiny neurons in the striatum
Huerta-Ocampo, I., Mena‐Segovia, J., & Bolam, J. P. (2013) · Brain Structure and Function · doi:10.1007/s00429-013-0601-z · Cited by 126
Striatal Cholinergic Interneurons Control Motor Behavior and Basal Ganglia Function in Experimental Parkinsonism
Maurice, N., Liberge, M., Jaouen, F., Ztaou, S., Hanini, M., Camon, J., Deisseroth, K. A., Amalric, M., Goff, L. K., & Beurrier, C. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.09.034 · Cited by 125
The therapeutic potential of cannabinoids for movement disorders
Kluger, B. M., Triolo, P. M., Jones, W. E., & Jankovic, J. J. (2015) · Movement Disorders · doi:10.1002/mds.26142 · Cited by 123
Cannabinoid Receptor Type 1 Protects Nigrostriatal Dopaminergic Neurons against MPTP Neurotoxicity by Inhibiting Microglial Activation
Chung, Y. C., Bok, E., Huh, S. H., Park, J., Yoon, S., Kim, S. R., Kim, Y., Maeng, S., Park, S. H., & Jin, B. K. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1102435 · Cited by 123
Widespread Decrease of Type 1 Cannabinoid Receptor Availability in Huntington Disease In Vivo
Laere, K. V., Casteels, C., Dhollander, I., Goffin, K. E., Grachev, I. D., Bormans, G. M., & Vandenberghe, W. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.077156 · Cited by 122
Regional changes in type 1 cannabinoid receptor availability in Parkinson's disease in vivo
Laere, K. V., Casteels, C., Lunskens, S., Goffin, K. E., Grachev, I. D., Bormans, G. M., & Vandenberghe, W. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.02.009 · Cited by 120
Development of a Unilaterally-lesioned 6-OHDA Mouse Model of Parkinson's Disease
Thiele, S. L., Warre, R., & Nash, J. E. (2012) · Journal of Visualized Experiments · doi:10.3791/3234 · Cited by 132
Pathway-specific modulation of nucleus accumbens in reward and aversive behavior via selective transmitter receptors
Hikida, T., Yawata, S., Yamaguchi, T., Danjo, T., Sasaoka, T., Wang, Y., & Nakanishi, S. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1220358110 · Cited by 128
Adenosine receptor neurobiology: overview
Chen, J.-F., Lee, C.-F., & Chern, Y. (2014) · International review of neurobiology · doi:10.1016/b978-0-12-801022-8.00001-5 · Cited by 119
Multiple Sources of Striatal Inhibition Are Differentially Affected in Huntington's Disease Mouse Models
Cepeda, C., Galvan, L., Holley, S. M., Rao, S. P., André, V. M., Botelho, E. P., Chen, J., Watson, J. B., Deisseroth, K. A., & Levine, M. S. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.2137-12.2013 · Cited by 119
Convergent evidence for abnormal striatal synaptic plasticity in dystonia
Peterson, D. A., B, T. J. S. A., & Howard Poizner, A. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.12.003 · Cited by 120
Modulation of the glutamatergic transmission by Dopamine: a focus on Parkinson, Huntington and Addiction diseases
Gardoni, F., & Bellone, C. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00025 · Cited by 129
Input- and Cell-Type-Specific Endocannabinoid-Dependent LTD in the Striatum
Wu, Y., Kim, J., Tawfik, V. L., Lalchandani, R. R., Scherrer, G., & Ding, J. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.12.005 · Cited by 117
Alpha-synuclein targets GluN2A NMDA receptor subunit causing striatal synaptic dysfunction and visuospatial memory alteration
Durante, V., de Iure, A., Loffredo, V., Vaikath, N. N., Risi, M. D., Paciotti, S., Quiroga‐Varela, A., Chiasserini, D., Mellone, M., Mazzocchetti, P., et al. (2019) · Brain · doi:10.1093/brain/awz065 · Cited by 117
Does dopamine mediate the psychosis-inducing effects of cannabis? A review and integration of findings across disciplines
Kuepper, R., Morrison, P. D., van Os, J., Murray, R. M., Kenis, G., & Henquet, C. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.05.031 · Cited by 116
Serotonin Induces Long-Term Depression at Corticostriatal Synapses
Mathur, B. N., Capik, N. A., Alvarez, V. A., & Lovinger, D. M. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.6250-10.2011 · Cited by 114
Levodopa-induced plasticity: a double-edged sword in Parkinson's disease?
Calabresi, P., Ghiglieri, V., Mazzocchetti, P., Corbelli, I., & Picconi, B. (2015) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2014.0184 · Cited by 119
A competitive model for striatal action selection
Bariselli, S., Fobbs, W. C., Creed, M. C., & Kravitz, A. V. (2018) · Brain Research · doi:10.1016/j.brainres.2018.10.009 · Cited by 123
Dynorphin/kappa-opioid receptor control of dopamine dynamics: Implications for negative affective states and psychiatric disorders
Tejeda, H. A., & Bonci, A. (2018) · Brain Research · doi:10.1016/j.brainres.2018.09.023 · Cited by 117
Cannabinoid–dopamine interactions in the physiology and physiopathology of the basal ganglia
García, C., Palomo‐Garo, C., Gómez‐Gálvez, Y., & Fernández‐Ruíz, J. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13215 · Cited by 111
Cholinergic Interneurons Amplify Thalamostriatal Excitation of Striatal Indirect Pathway Neurons in Parkinson’s Disease Models
Tanimura, A., Du, Y., Kondapalli, J., Wokosin, D. L., & Surmeier, D. J. (2019) · Neuron · doi:10.1016/j.neuron.2018.12.004 · Cited by 111
Immunomodulatory Effects of Dopamine in Inflammatory Diseases
Feng, Y., & Lü, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.663102 · Cited by 113
Cannabinoids and the Brain
Köfalvi, A. (2007) · Springer eBooks · doi:10.1007/978-0-387-74349-3 · Cited by 110
Cannabinoid pharmacology/therapeutics in chronic degenerative disorders affecting the central nervous system
Aymerich, M. S., Aso, E., Abellanas, M. A., Tolón, R. M., Ramos, J. A., Ferrer, I., Romero, J., & Fernández‐Ruíz, J. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.08.016 · Cited by 113
Npas1 + Pallidal Neurons Target Striatal Projection Neurons
Glajch, K. E., Kelver, D. A., Hegeman, D. J., Cui, Q., Xenias, H. S., Augustine, E. C., Hernández, V. M., Verma, N., Huang, T., Luo, M., et al. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.1720-15.2016 · Cited by 112
Cannabinoids in Parkinson's Disease
Bassi, M. S., Sancesario, A., Morace, R., Centonze, D., & Iezzi, E. (2017) · Cannabis and Cannabinoid Research · doi:10.1089/can.2017.0002 · Cited by 114
Timing and Location of Synaptic Inputs Determine Modes of Subthreshold Integration in Striatal Medium Spiny Neurons
Carter, A. G., Soler-Llavina, G. J., & Sabatini, B. L. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.2798-07.2007 · Cited by 109
Long-term behavioral and cell-type-specific molecular effects of early life stress are mediated by H3K79me2 dynamics in medium spiny neurons
Kronman, H., Torres-Berrío, A., Sidoli, S., Issler, O., Godino, A., Ramakrishnan, A., Mews, P., Lardner, C. K., Parise, E. M., Walker, D. M., et al. (2021) · Nature Neuroscience · doi:10.1038/s41593-021-00814-8 · Cited by 108
Neurocomputational models of motor and cognitive deficits in Parkinson’s disease
Wiecki, T. V., & Frank, M. J. (2010) · Progress in brain research · doi:10.1016/s0079-6123(10)83014-6 · Cited by 111
Inversion of Dopamine Responses in Striatal Medium Spiny Neurons and Involuntary Movements
Li, L., DeLong, M. R., & Papa, S. M. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.1176-08.2008 · Cited by 115
Acute ethanol suppresses glutamatergic neurotransmission through endocannabinoids in hippocampal neurons
Basavarajappa, B. S., Ninan, I., & Arancio, O. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05685.x · Cited by 108
GPR55: A therapeutic target for Parkinson's disease?
Celorrio, M., Rojo-Bustamante, E., Fernández‐Suárez, D., Sáez, E., de Mendoza, A. E., Müller, C. E., Ramírez, M. J., Oyarzábal, J., Franco, R., & Aymerich, M. S. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.08.017 · Cited by 109
Dysfunction of the corticostriatal pathway in autism spectrum disorders
Li, W., & Pozzo‐Miller, L. D. (2019) · Journal of Neuroscience Research · doi:10.1002/jnr.24560 · Cited by 114
Cellular Mechanisms Underlying Burst Firing in Substantia Nigra Dopamine Neurons
Blythe, S. G., Wokosin, D. L., Atherton, J. F., & Bevan, M. D. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.2961-09.2009 · Cited by 106
Striatal D2 Receptors Regulate Dendritic Morphology of Medium Spiny Neurons via Kir2 Channels
Cazorla, M., Shegda, M., Ramesh, B., Harrison, N. L., & Kellendonk, C. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.6056-11.2012 · Cited by 105
Striatal Signaling in L-DOPA-Induced Dyskinesia: Common Mechanisms with Drug Abuse and Long Term Memory Involving D1 Dopamine Receptor Stimulation
Murer, M. G., & Moratalla, R. (2011) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2011.00051 · Cited by 110
Reinforcement determines the timing dependence of corticostriatal synaptic plasticity in vivo
Fisher, S. D., Robertson, P. B., Black, M. J., Redgrave, P., Sagar, M. A., Abraham, W. C., & Reynolds, J. N. J. (2017) · Nature Communications · doi:10.1038/s41467-017-00394-x · Cited by 113
Plasticity of Hypothalamic Dopamine Neurons during Lactation Results in Dissociation of Electrical Activity and Release
Romanò, N., Yip, S. H., Hodson, D. J., Guillou, A., Parnaudeau, S., Kirk, S. E., Tronche, F., Bonnefont, X., Tissier, P. L., Bunn, S. J., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.4415-12.2013 · Cited by 104
Endocannabinoids and Retrograde Modulation of Synaptic Transmission
Ohno‐Shosaku, T., Tanimura, A., Hashimotodani, Y., & Kano, M. (2011) · The Neuroscientist · doi:10.1177/1073858410397377 · Cited by 104
Enhanced endocannabinoid tone as a potential target of pharmacotherapy
Toczek, M., & Malinowska, B. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.04.054 · Cited by 108
Dopamine D2 Receptor Overexpression Alters Behavior and Physiology in Drd2-EGFP Mice
Kramer, P. F., Christensen, C. H., Hazelwood, L. A., Dobi, A., Bock, R., Sibley, D. R., Mateo, Y., & Alvarez, V. A. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.4287-10.2011 · Cited by 103
Striatal plasticity and medium spiny neuron dendritic remodeling in parkinsonism
Deutch, A. Y., Colbran, R. J., & Winder, D. J. (2007) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(08)70012-9 · Cited by 107
Dopamine-Dependent Long-Term Depression Is Expressed in Striatal Spiny Neurons of Both Direct and Indirect Pathways: Implications for Parkinson's Disease
Bagetta, V., Picconi, B., Marinucci, S., Sgobio, C., Pendolino, V., Ghiglieri, V., Fusco, F. R., Giampà, C., & Calabresi, P. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.2236-11.2011 · Cited by 107
Initial elevations in glutamate and dopamine neurotransmission decline with age, as does exploratory behavior, in LRRK2 G2019S knock-in mice
Volta, M., Beccano-Kelly, D. A., Paschall, S. A., Cataldi, S., MacIsaac, S. E., Kuhlmann, N., Kadgien, C. A., Tatarnikov, I., Fox, J., Khinda, J., et al. (2017) · eLife · doi:10.7554/elife.28377 · Cited by 108
Advances in understanding l-DOPA-induced dyskinesia
Cenci, M. A., & Lindgren, H. S. (2007) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2008.01.004 · Cited by 104
LRRK2 overexpression alters glutamatergic presynaptic plasticity, striatal dopamine tone, postsynaptic signal transduction, motor activity and memory
Beccano-Kelly, D. A., Volta, M., Munsie, L. N., Paschall, S. A., Tatarnikov, I., Co, K., Chou, P., Cao, L.-P., Bergeron, S., Mitchell, E., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddu543 · Cited by 91
Mechanisms compensating for dopamine loss in early Parkinson disease
Brotchie, J. M., & Fitzer‐Attas, C. J. (2009) · Neurology · doi:10.1212/wnl.0b013e318198e0e9 · Cited by 101
Blockade of Cannabinoid Type 1 Receptors Augments the Antiparkinsonian Action of Levodopa without Affecting Dyskinesias in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Treated Rhesus Monkeys
Cao, X., Li, L., Hadcock, J. R., Iredale, P. A., Griffith, D. A., Menniti, F. S., Factor, S. A., Greenamyre, J. T., & Papa, S. M. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.125666 · Cited by 101
Dopaminergic modulation of striatal function and Parkinson’s disease
Zhai, S., Shen, W., Graves, S. M., & Surmeier, D. J. (2019) · Journal of Neural Transmission · doi:10.1007/s00702-019-01997-y · Cited by 100
SK channel modulation rescues striatal plasticity and control over habit in cannabinoid tolerance
Nazzaro, C., Greco, B., Cerovic, M., Baxter, P. S., Rubino, T., Trusel, M., Parolaro, D., Tkatch, T., Benfenati, F., Pedarzani, P., et al. (2012) · Nature Neuroscience · doi:10.1038/nn.3022 · Cited by 103
Genetic control of instrumental conditioning by striatopallidal neuron–specific S1P receptor Gpr6
Lobo, M. K., Cui, Y., Ostlund, S. B., Balleine, B. W., & Yang, X. W. (2007) · Nature Neuroscience · doi:10.1038/nn1987 · Cited by 100
Selective presynaptic enhancement of the prefrontal cortex to nucleus accumbens pathway by cocaine
Beroun, A., Lee, B. R., Huang, Y. H., Dong, Y., & Schlüter, O. M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206287110 · Cited by 102
Implicit Learning in Aging: Extant Patterns and New Directions
Rieckmann, A., & Bäckman, L. (2009) · Neuropsychology Review · doi:10.1007/s11065-009-9117-y · Cited by 99
Alterations in corticostriatal synaptic plasticity in mice overexpressing human α-synuclein
Watson, J. B., Hatami, A., David, H., Masliah, E., Roberts, K., Evans, C., & Levine, M. S. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.01.021 · Cited by 103
Distinct dopaminergic control of the direct and indirect pathways in reward-based and avoidance learning behaviors
Nakanishi, S., Hikida, T., & Yawata, S. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.04.026 · Cited by 103
Heterogeneous properties of central lateral and parafascicular thalamic synapses in the striatum
Ellender, T. J., Harwood, J., Kosillo, P., Capogna, M., & Bolam, J. P. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2012.245233 · Cited by 104
Functional Relevance of Endocannabinoid-Dependent Synaptic Plasticity in the Central Nervous System
Augustin, S. M., & Lovinger, D. M. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00508 · Cited by 100
The role of dopamine in modulating the structure and function of striatal circuits
Surmeier, D. J., Shen, W., Day, M., Gertler, T. S., Chan, C. S., Tian, X., & Plotkin, J. L. (2010) · Progress in brain research · doi:10.1016/s0079-6123(10)83008-0 · Cited by 97
Heteromerization of dopamine D2 receptors with dopamine D1 or D5 receptors generates intracellular calcium signaling by different mechanisms
Hasbi, A., O’Dowd, B. F., & George, S. R. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.09.011 · Cited by 97
Histone H3 Phosphorylation is Under the Opposite Tonic Control of Dopamine D2 and Adenosine A2A Receptors in Striatopallidal Neurons
Bertran‐Gonzalez, J., Håkansson, K., Borgkvist, A., Irinopoulou, T., Brami‐Cherrier, K., Usiello, A., Greengard, P., Hervé, D., Girault, J., Valjent, E., et al. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.228 · Cited by 97
Cannabinoids inhibit the synaptic uptake of adenosine and dopamine in the rat and mouse striatum
Pandolfo, P., Silveirinha, V., dos Santos‐Rodrigues, A., Venance, L., Ledent, C. A., Takahashi, R. N., Cunha, R. A., & Köfalvi, A. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.01.013 · Cited by 96
A Role for Dopamine-Mediated Learning in the Pathophysiology and Treatment of Parkinson’s Disease
Beeler, J. A., Frank, M. J., McDaid, J., Alexander, E. R., Turkson, S., Sarria, M. S. B., McGehee, D. S., & Zhuang, X. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.11.014 · Cited by 95
Key Modulatory Role of Presynaptic Adenosine A2AReceptors in Cortical Neurotransmission to the Striatal Direct Pathway
Quiroz, C., Luján, R., Uchigashima, M., Simões, A. P., Lerner, T. N., Borycz, J., Kachroo, A., Canas, P. M., Orrù, M., Schwarzschild, M. A., et al. (2009) · The Scientific World JOURNAL · doi:10.1100/tsw.2009.143 · Cited by 95
Self-citation
Differential striatal spine pathology in Parkinson’s disease and cocaine addiction: A key role of dopamine?
Villalba, R. M., & Smith, Y. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.07.011 · Cited by 97
Intratelencephalic corticostriatal neurons equally excite striatonigral and striatopallidal neurons and their discharge activity is selectively reduced in experimental parkinsonism
Ballion, B., Mallet, N. P., Bézard, E., Lanciego, J. L., & Gonon, F. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06192.x · Cited by 94
Dopamine modulation of excitatory currents in the striatum is dictated by the expression of D1 or D2 receptors and modified by endocannabinoids
André, V. M., Cepeda, C., Cummings, D. M., Jocoy, E. L., Fisher, Y. E., Yang, X. W., & Levine, M. S. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.07047.x · Cited by 94
Striatal direct and indirect pathways control decision-making behavior
Macpherson, T., Morita, M., & Hikida, T. (2014) · Frontiers in Psychology · doi:10.3389/fpsyg.2014.01301 · Cited by 105
Adenylyl Cyclase Type 5 Contributes to Corticostriatal Plasticity and Striatum-Dependent Learning
Kheirbek, M. A., Britt, J. P., Beeler, J. A., Ishikawa, Y., McGehee, D. S., & Zhuang, X. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3343-09.2009 · Cited by 93
Combined Activation of L-Type Ca2+ Channels and Synaptic Transmission Is Sufficient to Induce Striatal Long-Term Depression
Adermark, L., & Lovinger, D. M. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0280-07.2007 · Cited by 93
Optogenetic insights into striatal function and behavior
Lenz, J. D., & Lobo, M. K. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.04.018 · Cited by 95
Neural mechanisms of the nucleus accumbens circuit in reward and aversive learning
Hikida, T., Morita, M., & Macpherson, T. (2016) · Neuroscience Research · doi:10.1016/j.neures.2016.01.004 · Cited by 98
Striatal cholinergic interneurons and Parkinson's disease
Tanimura, A., Pancani, T., Lim, S. A. O., Tubert, C., Melendez-Zaidi, A. E., Shen, W., & Surmeier, D. J. (2017) · European Journal of Neuroscience · doi:10.1111/ejn.13638 · Cited by 94
Dopamine D2 receptor dysfunction is rescued by adenosine A2A receptor antagonism in a model of DYT1 dystonia
Napolitano, F., Pasqualetti, M., Usiello, A., Santini, E., Pacini, G., Sciamanna, G., Errico, F., Tassone, A., Dato, V. D., Martella, G., et al. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.03.003 · Cited by 91
The role of neuroplasticity in dopaminergic therapy for Parkinson disease
Zhuang, X., Mazzoni, P., & Kang, U. J. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.57 · Cited by 92
Looking for the role of cannabinoid receptor heteromers in striatal function
Ferré, S., Goldberg, S. R., Lluı́s, C., & Franco, R. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.06.076 · Cited by 89
Cannabis: A Treasure Trove or Pandora's Box?
Solymosi, K., & Köfalvi, A. (2016) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557516666161004162133 · Cited by 93
The endocannabinoid system and nondrug rewarding behaviours
Fattore, L., Melis, M., Fadda, P., Pistis, M., & Fratta, W. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.03.020 · Cited by 96
Developmental regulation and neuroprotective effects of striatal tonic GABAA currents
Santhakumar, V., Jones, R. T., & Módy, I. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.02.048 · Cited by 92

Authors: Kreitzer, A. C., & Malenka, R. C.
Affiliations: Stanford Medicine (US)
Corresponding author: Malenka, Robert C.
ORCID: Kreitzer, Anatol C.
Malenka, Robert C.
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2007-02
Volume: 445
Issue: 7128
Pages: 643-647
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/nature05506
OpenAlex: W2003314029
Cited by: 735
References: 35
Citations by year: 2026: 12 · 2025: 21 · 2024: 21 · 2023: 17 · 2022: 17 · 2021: 34 · 2020: 28 · 2019: 41 · 2018: 41 · 2017: 45 · 2016: 37 · 2015: 34 · 2014: 37 · 2013: 31 · 2012: 47
FWCI: 44.31
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
RePEc: Research Papers in Economics (submittedVersion)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords: striatum, indirect pathway, direct pathway, medium spiny neurons, dopamine D2 receptor, basal ganglia, motor impairment, synaptic plasticity, NMDA receptor currents, release probability, transgenic mouse model, therapeutic target, Huntington's disease, substantia nigra pars reticulata
MeSH terms: Animals, Benzamides, Carbamates, Disease Models, Animal, Dopamine, Mice, Transgenic, Morpholines, Naphthalenes, Neuronal Plasticity, Parkinson Disease, Piperidines, Psychomotor Performance, Pyrazoles, Reserpine, Synapses, Receptors, N-Methyl-D-Aspartate, Oxidopamine, Neostriatum, Receptors, Dopamine D2, Excitatory Postsynaptic Potentials, Long-Term Synaptic Depression, Receptor, Cannabinoid, CB1, Benzoxazines, Mice, Cannabinoid Receptor Modulators, Endocannabinoids, Dopamine D2 Receptor Antagonists, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks